BYOOVIZ, approved by the FDA in September 2021 as the first ophthalmology biosimilar in the US, has been commercially available since June 2022 Samsung Bioepis
After two years of co-development marked by close collaboration, Groupement Hospitalier Loos Haubourdin (GHLH) has renewed its trust in Intalio, a recognized leader in digital transformation for organizations,
The agreement builds upon a collaborative initiative launched earlier this year with the Monmouth County Vocational School District and Kean University. Through this program, up
MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg (MaaT013), its first in class treatment proposed for patients
Dedicated to expanding clinical trial access through collaboration with community-based healthcare systems, Javara announced a new strategic partnership with Cape Fear Valley Health. Leveraging Javara’s integrated teams and
Icon Group, a global leader in integrated cancer care, has announced a significant new agreement with Varian, a Siemens Healthineers company, involving an investment of
Latticework Capital Management, a growth oriented private equity firm focused on partnering with entrepreneurially-minded management teams to build leading healthcare companies, announced a strategic investment
Strategic Collaboration Brings Precision Micro-Neighborhood Targeting Healthcare Consumer Audiences to Linear and Connected TV Simulmedia, a national leader in data-driven TV and streaming advertising, announced a
Industry vendors team up to support radiation oncology clinics nationwide Fuse Oncology, an oncology healthcare software solutions provider, announces its partnership with Elekta, a leading innovator
Independent biopharmaceutical company Specialised Therapeutics is pleased to announce the expansion of its existing supply and distribution agreement with Incyte Biosciences International Sàrl, the Swiss-based affiliate
Fuel up with free Health Tech Insights
